Pharmafile Logo
Pharmafocus logo
Advanced Search

Medical Communications

Showing 15 posts of 6402 posts found.

amarin_logo

Amarin wins case against FDA to promote Vascepa for off-label uses

March 10, 2016 Medical Communications, Research and Development, Sales and Marketing Amarin, FDA, first amendment, off label, vascepa

Amarin has announced a settlement with the US Food and Drug Administration (FDA) that resolves the dispute over the Irish-based …
News
sharapova

Seven quick facts about meldonium – and why it will get Sharapova banned

March 10, 2016 Medical Communications, Research and Development 7 things, anti-doping, banned, maria sharapova, medlonum, reasons, susbtance

It’s made world headlines this week, but the drug meldonium would have been unknown to many before it emerged that …
Feature
wkd_logo

Tackling Chronic Kidney Disease – early action will aid prevention this World Kidney Day 2016

March 10, 2016 Medical Communications, Research and Development

Today (10th March) marks World Kidney Day 2016. Now in its 11th year, it is the largest such event focused …
Feature
dr_amit_nathwani

Sanofi appoints Novartis executive Dr Ameet Nathwani executive VP and CMO

March 10, 2016 Medical Communications

Sanofi has announced the appointment of Dr Ameet Nathwani as a new member of its Executive Committee, and to the …
Appointment
anna_cmo

Rigel names Anne-Marie Duliege chief medical officer

March 9, 2016 Medical Communications

Biotech firm Rigel Pharmaceuticals (Nasdaq: RIGL) named Anne-Marie Duliege its chief medical officer, replacing Elliott Grossbard, who is retiring.Dr Grossbard will remain …
Appointment
abpi_reception_close_7

Pharma industry’s contribution to NHS medicines bill tops £1 billion

March 9, 2016 Manufacturing and Production, Medical Communications, Research and Development ABPI, PPRS, goodwill, pharma industry

The pharmaceutical industry has now contributed over £1 billion to the Department of Health towards the cost of new medicines …
News
karl_ludwig_kley

Merck chief executive Karl-Ludwig Kley to step down in April

March 9, 2016 Medical Communications, Research and Development Denreon, Karl-Ludwig Kley, Merck, karl ludwig kley

 It has been announced that Karl-Ludwig Kley, chief executive officer at Merck, will step down from his position at the …
Appointment
biotrial_facility_rennes

French clinical trial tragedy “astonishing and unprecedented”, says report

March 9, 2016 Medical Communications, Research and Development Bial, Biotrial, France, clinical trial, death, rennes, tragedy

A report into the clinical trial tragedy in France in January has called the event “astonishing and unprecedented” but did …
News
merckincweb2

MSD joins charity-industry partnership Dementia Consortium

March 9, 2016 Medical Communications, Research and Development MSD, alzheimer's society, dementia, dementia consortium

The Dementia Consortium has welcomed MSD into the fold as a new partner in its global venture to accelerate drug …
News
sanofi_pasteur_msd

Sanofi Pasteur and MSD end European vaccines partnership

March 8, 2016 Medical Communications, Research and Development, Sales and Marketing MSD, Sanofi Pasteur, Sanofi pasteur msd, vaccines

Sanofi Pasteur and MSD have announced that they will end their joint vaccines operations in Europe, bringing an end to …
News
dr_virginia_jamieson_

Kuros Biosciences re-appoints chief medical officer

March 8, 2016 Medical Communications

Kuros Biosciences has announced the appointment of Dr Virginia Jamieson as chief medical officer and member of the executive board …
Appointment
bms

BMS criticises Scottish regulator over Opdivo skin cancer ‘no’

March 7, 2016 Medical Communications, Research and Development Bristol-Myers Sqibb, NICE, SMC, melanoma, opdivo

Bristol-Myers Squibb says the Scottish Medicines Consortium’s (SMC) decision not to recommend its immunotherapy Opdivo (nivolumab) as a monotherapy for …
News
teva_copy

Teva suffers EpiPen generic setback after FDA rejection

March 4, 2016 Medical Communications, Research and Development FDA, Teva, analphylaxis, approval, auto injector, auto-injector, rejection

The release of Teva Pharmaceuticals generic for the anaphylaxis treatment, EpiPen (epinephrine), is now expected to be severely delayed after …
News
rd_hands

BioMarin reports positive early-stage results for trial drug to treat CLN2 disease

March 4, 2016 Medical Communications

Biotechnology firm BioMarin Pharmaceutical has announced positive results from early stage trial for drug to treat neurodegenerative disease in children.  …
News
merck_logo_blue_rgb

Merck & Pfizer tie-up with Verastem to develop ovarian cancer drug

March 4, 2016 Medical Communications

German drug major Merck along with Pfizer has joined forces with Verastem to develop the trial drug candidate avelumab to …
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025